Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

StemCell Technologies

StemCell Technologies?uq=BoBgMMEs
1993 FOUNDED
M&A STATUS
901-1000 EMPLOYEES
Grant LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Developer of life science research products designed to isolate, culture and assay cells. The company's products include cell culture media and supplements, cell isolation products, primary and cultured cells, cytokines, matrices and substrates, enabling scientists to perform stem cell, immunology, cancer, regenerative medicine and cellular therapy research globally.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Parent Company
Primary Office
  • 1618 Station Street
  • Vancouver, British Columbia V6A 1B6
  • Canada

+1 (604) 000-0000

StemCell Technologies Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore StemCell Technologies‘s full profile, request access.

Request full access to PitchBook

StemCell Technologies Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore StemCell Technologies‘s full profile, request access.

Request full access to PitchBook

StemCell Technologies Executive Team (2)

Name Title Board
Seat
Contact
Info
Allen Eaves Founder, Chairman, Chief Executive Officer & President
Paul Buck Chief Financial Officer